INSYS Therapeutics, Inc. – Sells Sub-Lingual Fentanyl Product Subsys to Distributor of Fentanyl Nasal Spray (Lazanda) in Royalty-Based Deal

September 3, 2019 – Further to the Court's bidding procedures order [Docket No. 210], the Debtors notified the Court that, absent any further qualified bids, BTcP Pharma, LLC ("BTcP" or the "Buyer") had been designated as the successful bidder in respect of the Debtors' sale of  their Subsys® business (ie "the business of developing, manufacturing…